Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Bacterial Decolonization on Bacterial Burden Within Maternal-infant Dyads
NCT06541145Completed
- Sponsor
- Duke University
- Start
- Aug 2024
- Primary completion
- Oct 2024
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Open-label trial of mupirocin and chlorhexidine + cymenol gel in bacterial colonization (2 arms), sponsored by Duke University. Primary endpoints: Staph aureus burden within maternal-infant dyads at 12 months, Staph aureus epidemiology within maternal-infant dyads at 12 months and 2 more. Started Aug 2024; status: completed.
02
Drugs
mupirocinchlorhexidine + cymenol gel
03
Conditions
bacterial colonization
Beyond the preview
Go deeper on NCT06541145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06541145.